Cargando…
Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report
A 48‐year‐old male patient with Type 2 diabetes mellitus(T2D), on insulin replacement therapy, glipizide, and dapagliflozin presented with generalized weakness with weight loss of 40 pounds in 6 months ever since he was started on dapagliflozin. He was hemodynamically stable on arrival with a finger...
Autores principales: | Matli, Venkata Vinod Kumar, Fariduddin, Maria M., Asafo‐Agyei, Kwabena Oppong, Bansal, Nidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645174/ https://www.ncbi.nlm.nih.gov/pubmed/34917366 http://dx.doi.org/10.1002/ccr3.5144 |
Ejemplares similares
-
Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report
por: Chou, Yu-Mou, et al.
Publicado: (2018) -
Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019) -
Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report
por: Lee, In Hee, et al.
Publicado: (2020) -
Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice
por: Marcińczyk, Natalia, et al.
Publicado: (2023) -
Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report
por: Yeo, Sang Mok, et al.
Publicado: (2019)